Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Siemer

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Aktuelle Urologie|December 1, 2012
[Nephron-sparing surgery 2012]M Janssen, E A Treiyer, M Saar, et al.
Der Urologe. Ausg. A|September 19, 2019
[Trivialization of prostate cancer? : Stage shift and possible causes]M Saar, M S K M Abdeen, C Niklas, et al.
Klinische Padiatrie|April 22, 2011
Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study groupR Furtwängler, N Nourkami, M Alkassar, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 1998
Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancersO Türeci, U Sahin, E Vollmar, et al.
Plos One|May 4, 2018
Survival outcomes in patients with large (≥7cm) clear cell renal cell carcinomas treated with nephron-sparing surgery versus radical nephrectomy: Results of a multicenter cohort with long-term follow-upM W W Janssen, J Linxweiler, S Terwey, et al.
Der Urologe. Ausg. A|June 4, 2015
[Epigenetic regulation of urological tumors. Importance for prognosis and metastasis]J Heinzelmann, B Stubendorff, V Jung, et al.
British Journal of Cancer|August 16, 2006
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)J Atzpodien, H Kirchner, U Rebmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2025
Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRaM-O Grimm, J Bedke, J Nyarangi-Dix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2025
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trialL Bergmann, L Albiges, M Ahrens, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Aktuelle Urologie|December 1, 2012
[Nephron-sparing surgery 2012]M Janssen, E A Treiyer, M Saar, et al.
Der Urologe. Ausg. A|September 19, 2019
[Trivialization of prostate cancer? : Stage shift and possible causes]M Saar, M S K M Abdeen, C Niklas, et al.
Klinische Padiatrie|April 22, 2011
Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study groupR Furtwängler, N Nourkami, M Alkassar, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 1998
Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancersO Türeci, U Sahin, E Vollmar, et al.
Plos One|May 4, 2018
Survival outcomes in patients with large (≥7cm) clear cell renal cell carcinomas treated with nephron-sparing surgery versus radical nephrectomy: Results of a multicenter cohort with long-term follow-upM W W Janssen, J Linxweiler, S Terwey, et al.
Der Urologe. Ausg. A|June 4, 2015
[Epigenetic regulation of urological tumors. Importance for prognosis and metastasis]J Heinzelmann, B Stubendorff, V Jung, et al.
British Journal of Cancer|August 16, 2006
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)J Atzpodien, H Kirchner, U Rebmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 18, 2025
Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRaM-O Grimm, J Bedke, J Nyarangi-Dix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2025
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trialL Bergmann, L Albiges, M Ahrens, et al.
Pageof 6